Anika Therapeutics (ANIK) Scheduled to Post Earnings on Thursday

Anika Therapeutics (NASDAQ:ANIK) is scheduled to be issuing its quarterly earnings data after the market closes on Thursday, August 8th. Analysts expect the company to announce earnings of $0.23 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Anika Therapeutics (NASDAQ:ANIK) last posted its quarterly earnings data on Wednesday, May 8th. The biotechnology company reported $0.09 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.04). The business had revenue of $40.52 million during the quarter, compared to analysts’ expectations of $39.23 million. Anika Therapeutics had a negative net margin of 45.39% and a positive return on equity of 0.48%. On average, analysts expect Anika Therapeutics to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Anika Therapeutics Stock Performance

NASDAQ:ANIK opened at $26.07 on Wednesday. Anika Therapeutics has a fifty-two week low of $16.54 and a fifty-two week high of $29.11. The company has a fifty day moving average of $26.46 and a two-hundred day moving average of $25.64. The stock has a market capitalization of $380.28 million, a PE ratio of -4.97 and a beta of 0.83.

Wall Street Analyst Weigh In

ANIK has been the subject of a number of research analyst reports. Barrington Research reissued an “outperform” rating and set a $37.00 target price on shares of Anika Therapeutics in a report on Thursday, May 9th. Stephens restated an “equal weight” rating and issued a $24.00 price objective on shares of Anika Therapeutics in a report on Wednesday, May 29th.

About Anika Therapeutics

Anika Therapeutics, Inc, a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally.